Cent Eur J Public Health 2019, 27(3):245-250 | DOI: 10.21101/cejph.a4833

Antimicrobial susceptibility among urinary Escherichia coli isolates from female outpatients: age-related differences

Zorana Djordjević1, Marko Folić2,3, Violeta Ninković4, Dragan Vasiljević3,4, Slobodan Janković2,3
1 Department of Hospital Infections Control, Clinical Centrе Kragujevac, Kragujevac, Serbia
2 Clinical Pharmacology Department, Clinical Centrе Kragujevac, Kragujevac, Serbia
3 Faculty of Medical Sciences, University of Kragujevac, Kragujevac, Serbia
4 Public Health Institute Kragujevac, Kragujevac, Serbia

Objectives: Urinary tract infections (UTIs) are common problems in women, and important reason for visiting primary care physicians, resulting in substantial financial burden to community. The aim of this study was to determine the resistance rates of E. coli to commonly prescribed antimicrobial drugs for community-acquired UTIs in women and to establish the association between age and resistance to antibiotics among isolates of E. coli from urine.

Methods: The study was designed as a retrospective cross-sectional study during the 5-years period. It was conducted on a sample of urinary tract isolates of E. coli taken from women with community-acquired UTIs. After prevalence of E. coli resistance to antibiotics was established, the analysis of risk factors for emergence of resistance was conducted.

Results: There were 10,734 isolates of E. coli, comprising 70.62% of all samples analyzed. E. coli was the most frequently resistant to ampicillin (54.68%), followed by trimethoprim-sulphamethoxazole (37.46%), first and second generation cephalosporins (cephalexin and cefaclor) (29.53% both), and ciprofloxacin (23.80%). Less than 50% of E. coli isolates was sensitive to all three tested antibiotics, and nearly 13% acquired triple-resistance. Prevalence of isolates resistant to two or three agents was higher in the subgroup of women older than 65 years.

Conclusions: Empirical choice of antimicrobial agent for community-acquired non-complicated UTIs in women should be individualized on the basis of the patient's age, prevalence of resistance in the local community, and compliance history of the patient.

Keywords: urinary tract infections, community acquired, E. coli, resistance, utilization

Received: May 12, 2016; Revised: July 19, 2019; Accepted: July 19, 2019; Published: September 30, 2019  Show citation

ACS AIP APA ASA Harvard Chicago IEEE ISO690 MLA NLM Turabian Vancouver
Djordjević Z, Folić M, Ninković V, Vasiljević D, Janković S. Antimicrobial susceptibility among urinary Escherichia coli isolates from female outpatients: age-related differences. Cent Eur J Public Health. 2019;27(3):245-250. doi: 10.21101/cejph.a4833. PubMed PMID: 31580562.
Download citation

References

  1. Schappert SM, Rechtsteiner EA. Ambulatory medical care utilization estimates for 2007. Vital Health Stat 13. 2011;(169):1-38.
  2. Salvatore S, Salvatore S, Cattoni E, Siesto G, Serati M, Sorice P, et al. Urinary tract infections in women. Eur J Obstet Gynecol Reprod Biol. 2011;156(2):131-6. Go to original source... Go to PubMed...
  3. Naber KG, Schito G, Botto H, Palou J, Mazzei T. Surveillance study in Europe and Brazil on clinical aspects and Antimicrobial Resistance Epidemiology in Females with Cystitis (ARESC): implications for empiric therapy. Eur Urol. 2008;54(5):1164-75. Go to original source... Go to PubMed...
  4. Hooton TM. Uncomplicated urinary tract infection. N Engl J Med. 2012;366(11):1028-37. Go to original source... Go to PubMed...
  5. Guay DR. Contemporary management of uncomplicated urinary tract infections. Drugs. 2008;68(9):1169-205. Go to original source... Go to PubMed...
  6. Wagenlehner FM, Weidner W, Naber KG. An update on uncomplicated urinary tract infections in women. Curr Opin Urol. 2009;19(4):368-74. Go to original source... Go to PubMed...
  7. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing. Wayne: CLSI; 2010.
  8. Agency for Medicines and Medical Devices of Serbia [Internet]. [cited 2016 Apr 10]. Available from: http://www.alims.gov.rs/latin/o-agenciji/publikacije/. (In Serbian.)
  9. Gupta K, Hooton TM, Naber KG, Wullt B, Colgan R, Miller LG, et al. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. Clin Infect Dis. 2011;52(5):e103-20. doi: 10.1093/cid/ciq257. Go to original source... Go to PubMed...
  10. Grabe M, Bjerklund-Johansen TE, Botto H, Çek M, Naber KG, Pickard RS, et al. Guidelines on Urological Infections. European Association of Urology; 2013.
  11. Farrel DJ, Morrisey I, De Rubeis D, Robbins M, Felmingham D. A UK multi-center study of the antimicrobial susceptibility of bacterial pathogens causing urinary tract infection. J Infect. 2003;46(2):94-100. Go to original source... Go to PubMed...
  12. Kahlmeter G, Poulsen HO. Antimicrobial susceptibility of Escherichia coli from community-acquired urinary tract infections in Europe: the ECO.SENS study revisited. Int J Antimicrob Agents. 2012;39(1):45-51. Go to original source... Go to PubMed...
  13. Gyssens IC. Antibiotic policy. Int J Antimicrob Agents. 2011;38 Suppl:11-20. Go to original source... Go to PubMed...
  14. Kahlmeter G, Åhman J, Matuschek E. Antimicrobial resistance of Escherichia coli causing uncomplicated urinary tract infections: a European update for 2014 and comparison with 2000 and 2008. Infect Dis Ther. 2015;4(4):417-23. Go to original source... Go to PubMed...
  15. Schito GC, Naber KG, Botto H, Palou J, Mazzei T, Gualco L, et al. The ARESC study: an international survey on the antimicrobial resistance of pathogens involved in uncomplicated urinary tract infections. Int J Antimicrob Agents. 2009;34(5):407-41. Go to original source... Go to PubMed...
  16. Meumann EM, Mitchell BG, McGregor A, McBryde E, Cooley L. Urinary Escherichia coli antimicrobial susceptibility profiles and their relationship with community antibiotic use in Tasmania, Australia. Int J Antimicrob Agents. 2015;46(4):389-93. Go to original source... Go to PubMed...
  17. McIsaac WJ, Moineddin R, Meaney C, Mazzulli. Antibiotic-resistant Escherichia coli in women with acute cystitis in Canada. Can J Infect Dis Med Microbiol. 2013;24(3):143-9. Go to original source... Go to PubMed...
  18. Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection. 2011;39(4):333-40. Go to original source... Go to PubMed...
  19. Nicolle LE. Update in adult urinary tract infection. Curr Infect Dis Rep. 2011;13(6):552-60. Go to original source... Go to PubMed...
  20. Wagenlehner FM, Schmiemann G, Hoyme U, Fünfstück R, Hummers-Pradier E, Kaase M, et al. National S3 guideline on uncomplicated urinary tract infection: recommendations for treatment and management of uncomplicated community-acquired bacterial urinary tract infections in adult patients.Urologe A. 2011;50(2):153-69. Go to original source... Go to PubMed...
  21. Gupta K, Sahm DF, Mayfield D, Stamm WE. Antimicrobial resistance among uropathogens that cause community-acquired urinary tract infections in women: a nationwide analysis. Clin Infect Dis. 2001;33(1):89-94. Go to original source... Go to PubMed...
  22. Alós JI, Serrano MG, Gómez-Garcés JL, Perianes J. Antibiotic resistance of Escherichia coli from community-acquired urinary tract infections in relation to demographic and clinical data. Clin Microbiol Infect. 2005;11(3):199-203. Go to original source... Go to PubMed...
  23. Miotla P, Romanek-Piva K, Bogusiewicz M, Markut-Miotla E, Adamiak A, Wróbel A, et al. Antimicrobial resistance patterns in women with positive urine culture: does menopausal status make a significant difference? Biomed Res Int. 2017;2017:4192908. doi: 10.1155/2017/4192908. Go to original source... Go to PubMed...
  24. Gobernado M, Valdés L, Alós JI, García-Rey C, Dal-Ré R, García-de-Lomas J; Spanish Surveillance Group for Urinary Pathogens. Antimicrobial susceptibility of clinical Escherichia coli isolates from uncomplicated cystitis in women over a 1-year period in Spain. Rev Esp Quimioter. 2007;20(1):68-76. Go to PubMed...
  25. Rowe T, Juthani-Mehta M. Urinary tract infection in older adults. Aging Health. 2013; 9(5). doi: 10.2217/ahe.13.38. Go to original source... Go to PubMed...
  26. Matthews SJ, Lancaster JW. Urinary tract infections in the elderly population. Am J Geriatr Pharmacother. 2011;9(5):286-309. Go to original source... Go to PubMed...
  27. Sedláková MH, Urbánek K, Vojtová V, Suchánková H, Imwensi P, Kolář M. Antibiotic consumption and its influence on the resistance in Enterobacteriaceae. BMC Res Notes. 2014;7:454. doi: 10.1186/1756-0500-7-454. Go to original source... Go to PubMed...
  28. Joseph NM, Bhanupriya B, Shewade DG, Harish BN. Relationship between antimicrobial consumption and the incidence of antimicrobial resistance in Escherichia coli and Klebsiella pneumoniae isolates. J Clin Diagn Res. 2015;9(2):DC08-12. Go to original source... Go to PubMed...
  29. Bergman M, Nyberg ST, Huovinen P, Paakkari P, Hakanen AJ; Finnish Study Group for Antimicrobial Resistance. Association between antimicrobial consumption and resistance in Escherichia coli. Antimicrob Agents Chemother. 2009;53(3):912-7. Go to original source... Go to PubMed...
  30. Urbánek K, Kolár M, Strojil J, Koukalová D, Cekanová L, Hejnar P. Utilization of fluoroquinolones and Escherichia coli resistance in urinary tract infection: inpatients and outpatients. Pharmacoepidemiol Drug Saf. 2005;14(10):741-5. Go to original source... Go to PubMed...
  31. Guneysel O, Onur O, Erdede M, Denizbasi A. Trimethoprim/sulfamethoxazole resistance in urinary tract infections. J Emergency Med. 2009;36(4):338-41. Go to original source... Go to PubMed...